Clinical Trial Detail

NCT ID NCT02138383
Title Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

pancreatic adenocarcinoma

Therapies

Enzalutamide

Nab-paclitaxel

Gemcitabine

Age Groups: adult

Additional content available in CKB BOOST